DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Ji RR, Chasalow SD, Wang L et al.
An immune-active tumor microenvironment favors clinical response to ipilimumab.
Cancer Immunol Immunother 2012;
61: 1019-1031
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.